Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Qing Shu, Qingqing Fan, Bingzhu Hua, Hang Liu, Shiying Wang, Yunxing Liu, Yao Yao, Han Xie & Weihong Ge. (2021) Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients. Pharmacogenomics and Personalized Medicine 14, pages 713-722.
Read now
Read now
Zhenwei Jiang & Nan Hu. (2021) Effect of UGT Polymorphisms on Pharmacokinetics and Adverse Reactions of Mycophenolic Acid in Kidney Transplant Patients. Pharmacogenomics 22:15, pages 1019-1040.
Read now
Read now
Henrike Bruckmueller & Ingolf Cascorbi. (2021) ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 369-396.
Read now
Read now
Hai le Ba, Litaty Mbatchi, Florence Gattacceca, Alexandre Evrard, Bruno Lacarelle, Benoit Blanchet, Joseph Ciccolini & Sébastien Salas. (2020) Pharmacogenetics and Pharmacokinetics Modeling of Unexpected and Extremely Severe Toxicities After Sorafenib Intake. Pharmacogenomics 21:3, pages 173-179.
Read now
Read now
Li-qing Li, Di-na Chen, Chuan-jiang Li, Qing-ping Li, Yan Chen, Ping Fang, Ping Zheng, Hui-jie Lu, De-mei Ye, Hao-yang Wan, Jie Li & Liang Li. (2018) Impact of UGT2B7 and ABCC2 Genetic Polymorphisms on Mycophenolic Acid Metabolism in Chinese Renal Transplant Recipients. Pharmacogenomics 19:17, pages 1323-1334.
Read now
Read now
Oliver Bruhn & Ingolf Cascorbi. (2014) Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance. Expert Opinion on Drug Metabolism & Toxicology 10:10, pages 1337-1354.
Read now
Read now
Brian Murray, Emily Hawes, Ruth-Ann Lee, Robert Watson & Mary W Roederer. (2013) Genes and Beans: Pharmacogenomics of Renal Transplant. Pharmacogenomics 14:7, pages 769-781.
Read now
Read now
Nicolas Picard & Pierre Marquet. (2011) The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation. Expert Opinion on Drug Metabolism & Toxicology 7:6, pages 731-743.
Read now
Read now
Katherine A Barraclough, Katie J Lee & Christine E Staatz. (2010) Pharmacogenetic Influences on Mycophenolate Therapy. Pharmacogenomics 11:3, pages 369-390.
Read now
Read now
Nicole K Bruchet & Mary HH Ensom. (2009) Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review. Expert Opinion on Drug Metabolism & Toxicology 5:9, pages 1079-1097.
Read now
Read now
Articles from other publishers (34)
Chinedum P. BabalolaOlayinka KotilaOtito Frances Iwuchukwu. (2023) The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes. American Journal of Pharmacotherapy and Pharmaceutical Sciences 2, pages 24.
Crossref
Crossref
Sha‐Sha Sun, Kun Shao, Jia‐Qian Lu, Hui‐Min An, Hao‐Qiang Shi, Pei‐Jun Zhou & Bing Chen. (2022) Influence of Calcineurin Inhibitors and Genetic Polymorphism of Transporters on Enterohepatic Circulation and Exposure of Mycophenolic Acid in Chinese Adult Renal Allograft Recipients. The Journal of Clinical Pharmacology 63:4, pages 410-420.
Crossref
Crossref
Daniel Brazeau, Calvin J. Meaney, Joseph D. Consiglio, Gregory E. Wilding, Louise M. Cooper, Rocco C. Venuto & Kathleen M. Tornatore. (2021)
Association of
ABCC2
Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients
. The Journal of Clinical Pharmacology 61:12, pages 1592-1605.
Crossref
Crossref
Mingkwan Na Takuathung, Wannachai Sakuludomkan & Nut Koonrungsesomboon. (2021) The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis. Clinical Pharmacokinetics 60:10, pages 1291-1302.
Crossref
Crossref
Stein BerganMercè BrunetDennis A. HesselinkKamisha L. Johnson-DavisPaweł K. KunickiFlorian LemaitrePierre MarquetMariadelfina MolinaroOfelia NocetiSmita PattanaikTomasz PawinskiChristoph SegerMaria ShipkovaJesse J. SwenTeun van GelderRaman VenkataramananEberhard WielandJean-Baptiste WoillardTom C. ZwartMarkus J. BartenKlemens BuddeMaja-Theresa DieterlenLaure ElensVincent HaufroidSatohiro MasudaOlga MillanTomoyuki MizunoDirk J. A. R. MoesMichael OellerichNicolas PicardLinda SalzmannBurkhard TönshoffRon H. N. van SchaikNils Tore VetheAlexander A. VinksPierre WallemacqAnders Åsberg & Loralie J. Langman. (2021) Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic Drug Monitoring 43:2, pages 150-200.
Crossref
Crossref
E. E. J. Kasteel, K. Darney, N. I. Kramer, J. L. C. M. Dorne & L. S. Lautz. (2020) Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors. Archives of Toxicology 94:8, pages 2637-2661.
Crossref
Crossref
Desmond Y H Yap, Chun Hay Tam, Susan Yung, Sunny Wong, Colin S O Tang, Temy M Y Mok, Catherine K Y Yuen, Maggie K M Ma, Chak Sing Lau & Tak Mao Chan. (2020) Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis. Nephrology Dialysis Transplantation 35:5, pages 810-818.
Crossref
Crossref
Xiao-yan Qiu, Zhuo Wu, Qin-xia Xu, Chang-cheng Sheng & Zheng Jiao. 2020. Pharmacogenomics in Precision Medicine. Pharmacogenomics in Precision Medicine
83
106
.
Zhan-zhang Wang, Yue-feng Zhang, Wen-can Huang, Xi-pei Wang, Xiao-jiao Ni, Hao-yang Lu, Jin-qing Hu, Shu-hua Deng, Xiu-qing Zhu, Huan-shan Xie, Hong-zhen Chen, Ming Zhang, Chang Qiu, Yu-guan Wen & De-wei Shang. (2019) Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy. Frontiers in Pharmacology 10.
Crossref
Crossref
Matthew W. Linakis, Sarah F. Cook, Shaun S. Kumar, Xiaoxi Liu, Diana G. Wilkins, Roger Gaedigk, Andrea Gaedigk, Catherine M. T. Sherwin & John N. van den Anker. (2018) Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study. Clinical Pharmacokinetics 57:10, pages 1325-1336.
Crossref
Crossref
Ingolf Cascorbi. 2018. Pharmacogenetics. Pharmacogenetics
275
296
.
Sinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, Xin Qiu, Yonathan Brhane, Qin Kuang, Sharon Marsh, Sevtap Savas, Zhuo Chen, Dangxiao Cheng, Natasha B. Leighl, Glenwood Goss, Scott A. Laurie, Lesley Seymour, Penelope A. Bradbury, Frances A. Shepherd, Ming Sound Tsao, Bingshu E. Chen, Wei Xu & Geoffrey Liu. (2016) ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. Cancer Epidemiology 41, pages 50-56.
Crossref
Crossref
Marelize Swart, Jonathan Evans, Michelle Skelton, Sandra Castel, Lubbe Wiesner, Peter J. Smith & Collet Dandara. (2016) An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3′-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients. Frontiers in Genetics 6.
Crossref
Crossref
Jesus Ruiz, María Herrero, Virginia Bosó, Juan Megías, David Hervás, Jose Poveda, Juan Escrivá, Amparo Pastor, Amparo Solé & Salvador Aliño. (2015) Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. International Journal of Molecular Sciences 16:9, pages 20168-20182.
Crossref
Crossref
Xiao-chun Xie, Jun Li, Hong-yang Wang, Hong-liang Li, Jing Liu, Qian Fu, Jia-wen Huang, Chen Zhu, Guo-ping Zhong, Xue-ding Wang, Ping-ping Sun, Min Huang, Chang-xi Wang & Jia-li Li. (2015) Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients. Acta Pharmacologica Sinica 36:5, pages 644-650.
Crossref
Crossref
Pengmei Li, Nauras Shuker, Dennis A. Hesselink, Ron H. N. van Schaik, Xianglin Zhang & Teun van Gelder. (2014) Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?. Transplant International 27:10, pages 994-1004.
Crossref
Crossref
Nayoung Han, Hwi-yeol Yun, In-Wha Kim, Yoon Jung Oh, Yon Su Kim & Jung Mi Oh. (2014) Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients. European Journal of Clinical Pharmacology 70:10, pages 1211-1219.
Crossref
Crossref
Azza A.K. El-Sheikh, Jan B. Koenderink, Alfons C. Wouterse, Petra H.H. van den Broek, Vivienne G.M. Verweij, Rosalinde Masereeuw & Frans G.M. Russel. (2014) Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. Translational Research 164:1, pages 46-56.
Crossref
Crossref
Yan Liu, You Yin, Qi Sheng, Xiaotong Lu, Fang Wang, Zhiyan Lin, Huaiping Tian, Ajing Xu & Jian Zhang. (2014) Association of ABCC2 −24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia. PLoS ONE 9:1, pages e82681.
Crossref
Crossref
J.C. Stingl, H. Bartels, R. Viviani, M.L. Lehmann & J. Brockmöller. (2014) Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review. Pharmacology & Therapeutics 141:1, pages 92-116.
Crossref
Crossref
In-Wha Kim, Hwi-yeol Yun, Boyoon Choi, Nayoung Han, Myeong Gyu Kim, Seonyang Park & Jung Mi Oh. (2013) Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation. European Journal of Clinical Pharmacology 69:8, pages 1543-1551.
Crossref
Crossref
Azrin N. Abd Rahman, Susan E. Tett & Christine E. Staatz. (2013) Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease. Clinical Pharmacokinetics 52:5, pages 303-331.
Crossref
Crossref
Dong Guo, Liang-Fang Pang, Yang Han, Hong Yang, Guo Wang, Zhi-rong Tan, Wei Zhang & Hong-Hao Zhou. (2012) Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers. European Journal of Clinical Pharmacology 69:4, pages 843-849.
Crossref
Crossref
Anne T. Nies. 2013. Pharmacogenomics of Human Drug Transporters. Pharmacogenomics of Human Drug Transporters
345
364
.
Adam Frymoyer, Davide Verotta, Pamala Jacobson & Janel Long‐Boyle. (2013) Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors. British Journal of Clinical Pharmacology 75:2, pages 463-475.
Crossref
Crossref
Laure Elens, Dennis A. Hesselink, Ron H. N. van Schaik & Teun van Gelder. (2012) Pharmacogenetics in Kidney Transplantation. Molecular Diagnosis & Therapy 16:6, pages 331-345.
Crossref
Crossref
Robert Dupuis, Andrea Yuen & Federico Innocenti. (2012) The influence of UGT polymorphisms as biomarkers in solid organ transplantation. Clinica Chimica Acta 413:17-18, pages 1318-1325.
Crossref
Crossref
Nauras Shuker, Rachida Bouamar, Willem Weimar, Ron.H.N. van Schaik, Teun van Gelder & Dennis A. Hesselink. (2012) ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantation. Clinica Chimica Acta 413:17-18, pages 1326-1337.
Crossref
Crossref
Geng Fang, Jiao Zheng, Dao Yi-Jun, Qiu Xiao-Yan, Ding Jun-Jie, Shi Xiao-Jin, Li Zhong-Dong & Zhong Ming-Kang. (2012) The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals. Clinica Chimica Acta 413:7-8, pages 683-690.
Crossref
Crossref
Nicolas Picard & Pierre Marquet. 2012. Pharmacogenomics in Clinical Therapeutics. Pharmacogenomics in Clinical Therapeutics
70
97
.
Lillian S. L. Ting, Marie‐Odile Benoit‐Biancamano, Olivier Bernard, K. Wayne Riggs, Chantal Guillemette & Mary H. H. Ensom. (2012) Pharmacogenetic Impact of UDP‐Glucuronosyltransferase Metabolic Pathway and Multidrug Resistance—Associated Protein 2 Transport Pathway on Mycophenolic Acid in Thoracic Transplant Recipients: An Exploratory Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30:11, pages 1097-1108.
Crossref
Crossref
Melanie S. Joy, Tammy Boyette, Yichun Hu, Jinzhao Wang, Mary La, Susan L. Hogan, Paul W. Stewart, Ronald J. Falk, Mary Anne Dooley & Philip C. Smith. (2010) Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis. European Journal of Clinical Pharmacology 66:11, pages 1119-1130.
Crossref
Crossref
Curtis D. Klaassen & Lauren M. Aleksunes. (2010) Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation. Pharmacological Reviews 62:1, pages 1-96.
Crossref
Crossref
G Zaza, S Granata, F Sallustio, G Grandaliano & F P Schena. (2010) Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. Clinical and Experimental Immunology 159:3, pages 268-280.
Crossref
Crossref